Market Closed -
Nyse
04:00:03 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
6.3
USD
|
+0.96%
|
|
+3.45%
|
-49.80%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,629
|
6,647
|
5,096
|
2,591
|
-
|
-
|
Enterprise Value (EV)
1 |
9,637
|
6,194
|
5,027
|
2,404
|
2,386
|
2,448
|
P/E ratio
|
-24.8
x
|
-62.1
x
|
-19.6
x
|
-18.3
x
|
-41.2
x
|
-50
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.8
x
|
2.45
x
|
1.18
x
|
0.42
x
|
0.34
x
|
0.29
x
|
EV / Revenue
|
5.26
x
|
2.29
x
|
1.16
x
|
0.39
x
|
0.31
x
|
0.28
x
|
EV / EBITDA
|
-250
x
|
1,457
x
|
-52.9
x
|
-60.3
x
|
87.8
x
|
31.2
x
|
EV / FCF
|
-62.3
x
|
-42.4
x
|
-29.2
x
|
-16.6
x
|
-80
x
|
966
x
|
FCF Yield
|
-1.61%
|
-2.36%
|
-3.42%
|
-6.01%
|
-1.25%
|
0.1%
|
Price to Book
|
9.89
x
|
6.39
x
|
7.82
x
|
4.38
x
|
4.45
x
|
-
|
Nbr of stocks (in thousands)
|
393,655
|
411,855
|
406,041
|
411,262
|
-
|
-
|
Reference price
2 |
27.00
|
16.14
|
12.55
|
6.300
|
6.300
|
6.300
|
Announcement Date
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,218
|
1,834
|
2,708
|
4,316
|
6,167
|
7,591
|
8,874
|
EBITDA
1 |
-
|
-38.62
|
4.251
|
-95
|
-39.88
|
27.17
|
78.54
|
EBIT
1 |
-
|
-394
|
-120.4
|
-231.9
|
-165.7
|
-107.8
|
-92.82
|
Operating Margin
|
-
|
-21.49%
|
-4.45%
|
-5.37%
|
-2.69%
|
-1.42%
|
-1.05%
|
Earnings before Tax (EBT)
1 |
-
|
-404.6
|
-105.7
|
-194.5
|
-147.3
|
-46.18
|
-48.48
|
Net income
1 |
-60.05
|
-406.5
|
-106.6
|
-262.6
|
-141.2
|
-65.08
|
-36
|
Net margin
|
-4.93%
|
-22.17%
|
-3.93%
|
-6.08%
|
-2.29%
|
-0.86%
|
-0.41%
|
EPS
2 |
-19.54
|
-1.090
|
-0.2600
|
-0.6400
|
-0.3451
|
-0.1529
|
-0.1260
|
Free Cash Flow
1 |
-
|
-154.7
|
-146.2
|
-172
|
-144.6
|
-29.81
|
2.533
|
FCF margin
|
-
|
-8.44%
|
-5.4%
|
-3.99%
|
-2.34%
|
-0.39%
|
0.03%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
3.23%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/21
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
462.9
|
653.4
|
670.1
|
694.9
|
689.8
|
1,136
|
1,149
|
1,216
|
1,056
|
1,604
|
1,560
|
1,544
|
1,458
|
1,978
|
1,936
|
EBITDA
1 |
-26.69
|
12.03
|
7.496
|
-4.653
|
-10.62
|
23.86
|
10.26
|
-5.777
|
-137.1
|
29.05
|
-6.704
|
-16.97
|
-43.37
|
51.95
|
18.32
|
EBIT
1 |
-47.87
|
-0.743
|
-21.05
|
-29.52
|
-69.12
|
6.261
|
-29.82
|
-48.97
|
-164.3
|
-7.178
|
-37.49
|
-52.37
|
-71.66
|
7.35
|
-24.2
|
Operating Margin
|
-10.34%
|
-0.11%
|
-3.14%
|
-4.25%
|
-10.02%
|
0.55%
|
-2.6%
|
-4.03%
|
-15.56%
|
-0.45%
|
-2.4%
|
-3.39%
|
-4.92%
|
0.37%
|
-1.25%
|
Earnings before Tax (EBT)
1 |
-57.25
|
0.655
|
-20.46
|
-29.94
|
-55.94
|
14.2
|
-15.72
|
-30.27
|
-166.9
|
3.114
|
-35.83
|
-39.37
|
-74.63
|
31.99
|
-9.745
|
Net income
1 |
-56.72
|
1.23
|
-20.65
|
-30.67
|
-56.47
|
16.02
|
-16.75
|
-31.44
|
-230.4
|
-6.064
|
-32.96
|
-39.29
|
-68.55
|
28.15
|
-11.82
|
Net margin
|
-12.25%
|
0.19%
|
-3.08%
|
-4.41%
|
-8.19%
|
1.41%
|
-1.46%
|
-2.59%
|
-21.82%
|
-0.38%
|
-2.11%
|
-2.54%
|
-4.7%
|
1.42%
|
-0.61%
|
EPS
2 |
-0.1400
|
0.002900
|
-0.0500
|
-0.0700
|
-0.1400
|
0.0376
|
-0.0400
|
-0.0800
|
-0.5700
|
-0.0148
|
-0.0801
|
-0.0969
|
-0.1670
|
0.0665
|
-0.0277
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/22
|
5/5/22
|
8/4/22
|
11/3/22
|
3/1/23
|
5/9/23
|
8/3/23
|
11/2/23
|
2/27/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
992
|
454
|
69
|
187
|
205
|
143
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-155
|
-146
|
-172
|
-145
|
-29.8
|
2.53
|
ROE (net income / shareholders' equity)
|
-
|
-101%
|
-9.99%
|
-30.8%
|
-27.8%
|
-10.7%
|
-7.88%
|
ROA (Net income/ Total Assets)
|
-
|
-40%
|
-6.49%
|
-15.3%
|
-11.5%
|
-2.39%
|
-
|
Assets
1 |
-
|
1,016
|
1,642
|
1,719
|
1,233
|
2,720
|
-
|
Book Value Per Share
2 |
-
|
2.730
|
2.520
|
1.600
|
1.440
|
1.420
|
-
|
Cash Flow per Share
2 |
-
|
-0.4000
|
-0.3200
|
-0.3800
|
0
|
0.0900
|
-
|
Capex
1 |
-
|
6.56
|
15.4
|
15.8
|
18.8
|
21.8
|
20.7
|
Capex / Sales
|
-
|
0.36%
|
0.57%
|
0.37%
|
0.31%
|
0.29%
|
0.23%
|
Announcement Date
|
3/18/21
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Average target price
7.944
USD Spread / Average Target +26.10% Consensus |
1st Jan change
|
Capi.
|
---|
| -49.80% | 2.59B | | -23.90% | 2.81B | | -22.24% | 2.63B | | -45.13% | 237M | | -2.11% | 217M | | -44.86% | 180M | | -32.40% | 115M |
Doctor's Office
|